NCT02287428 2026-04-17Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBMDana-Farber Cancer InstitutePhase 1 Active not recruiting56 enrolled
NCT02886065 2026-03-13A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MMMassachusetts General HospitalPhase 1 Active not recruiting19 enrolled